China’s Wuhan Institute files to patent use of remdesivir for coronavirus

In collaboration with Gilead, phase III trial will be conducted to assess remdesivir. The drug was originally developed to treat Ebola but wasn’t effective. Preclinical assays have suggested it might be effective and it has been given to patient in US for compassionate use.


Biospace Inc.